rs128624219
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The ENST00000218104.6(ABCD1):c.1202G>A(p.Arg401Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R401W) has been classified as Pathogenic.
Frequency
Consequence
ENST00000218104.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCD1 | NM_000033.4 | c.1202G>A | p.Arg401Gln | missense_variant | 3/10 | ENST00000218104.6 | NP_000024.2 | |
LOC124905226 | XR_007068350.1 | n.4119C>T | non_coding_transcript_exon_variant | 2/2 | ||||
ABCD1 | XM_047441916.1 | c.1202G>A | p.Arg401Gln | missense_variant | 3/11 | XP_047297872.1 | ||
ABCD1 | XM_047441917.1 | c.1202G>A | p.Arg401Gln | missense_variant | 3/8 | XP_047297873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCD1 | ENST00000218104.6 | c.1202G>A | p.Arg401Gln | missense_variant | 3/10 | 1 | NM_000033.4 | ENSP00000218104 | P1 | |
PLXNB3-AS1 | ENST00000434284.1 | n.581-273C>T | intron_variant, non_coding_transcript_variant | 3 | ||||||
ABCD1 | ENST00000443684.2 | n.205G>A | non_coding_transcript_exon_variant | 2/6 | 3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | May 12, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The missense variant p.R401Q in ABCD1 (NM_000033.4) causes the same amino acid change as a previously established pathogenic variant. The p.R401Q variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. There is a small physicochemical difference between arginine and glutamine, which is not likely to impact secondary protein structure as these residues share similar properties. The p.R401Q missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 401 of ABCD1 is conserved in all mammalian species. The nucleotide c.1202 in ABCD1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 01, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 401 of the ABCD1 protein (p.Arg401Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with X-linked adrenoleukodystrophy (PMID: 8566952, 15811009, 21966424, 23419472, 26388597). In at least one individual the variant was observed to be de novo. This variant is also known as G1588A. ClinVar contains an entry for this variant (Variation ID: 11300). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg401 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been observed in individuals with ABCD1-related conditions (PMID: 10190819, 22479560), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Apr 17, 2019 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1994 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 16, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36801247, 36380532, 10551832, 26388597, 7849723, 10980539, 8566952, 33920672, 34826210, 34649108, 10737980, 11336405, 20800589, 21889498, 21068741, 33794216, 21966424, 22280810, 30902905, 26454440, 12402273, 15811009, 23419472, 33247909, 34291142, 7668254, 21300044, 35676282) - |
not specified Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 21, 2018 | The ABCD1 c.1202G>A; p.Arg401Gln variant (rs128624219) has been described in several individuals and families affected with X-linked adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN; see link to ALD ABCD1 database and references therein, Kemp 2001, Krasemann 1996, Kumar 2011, Shimozawa 2011, Watkins 1995). It contains an entry in ClinVar (Variation ID: 11300), and is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The arginine at codon 401 is highly conserved, and computational algorithms (PolyPhen-2, SIFT) predict that this variant is deleterious. Additionally, other variants at this codon (c.1201C>T; p.Arg401Trp and c.1201C>G; p.Arg401Gly) have been described in several individuals with ALD and are considered pathogenic (see link to ALD ABCD1 database and references therein, Shimozawa 2011). Based on available information, this variant is considered pathogenic. References: ALD ABCD1 database: https://adrenoleukodystrophy.info/mutations-and-variants-in-abcd1 Kemp S et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001 Dec;18(6):499-515. Krasemann E et al. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy. Hum Genet. 1996 Feb;97(2):194-7. Kumar N et al. Genomic profiling identifies novel mutations and SNPs in ABCD1 gene: a molecular, biochemical and clinical analysis of X-ALD cases in India. PLoS One. 2011;6(9):e25094. Shimozawa N et al. X-linked adrenoleukodystrophy: diagnostic and follow-up system in Japan. J Hum Genet. 2011 Feb;56(2):106-9. Watkins P et al. Altered expression of ALDP in X-linked adrenoleukodystrophy. Am J Hum Genet. 1995 Aug;57(2):292-301. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at